SKI Market

A+| A| A-|

Indian Indices

Sensex

73,983.18 64.42
( 0.09%)

Global Indices

Nasdaq

50,884.98 77.97
(0.15%)

Dow Jones

7,407.31 -19.42
(-0.26%)

Hang Seng

64,234.22 -1,182.41
(-1.81%)

Nikkei 225

10,242.24 -130.96
(-1.26%)

Forex

USD-INR

95.53 0.30
(0.32%)

EUR-INR

110.14 0.47
(0.43%)

GBP-INR

127.43 0.45
(0.36%)

JPY-INR

0.60 0.00
(0.41%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524715

INE044A01036

93.2373503

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SUNPHARMA

142.24

426937.66

EPS(TTM)

Face Value()

Div & Yield %

12.51

0.9

Back

sanwaria consumer ltd

Board of Jindal Saw recommends final dividend

Apr 28,2026

Jindal Saw announced that the Board of Directors of the Company at its meeting held on 27 April 2026, inter alia, have recommended the final dividend of Rs 2 per equity Share (i.e. 200%) , subject to the approval of the shareholders.

73,983.18 64.42 ( 0.09%)

50,884.98 77.97 (0.15%)

7,407.31 -19.42 (-0.26%)

64,234.22 -1,182.41 (-1.81%)

10,242.24 -130.96 (-1.26%)

95.53 0.30 (0.32%)

110.14 0.47 (0.43%)

127.43 0.45 (0.36%)

0.60 0.00 (0.41%)